Iceland· IS-MTnr 970044 (IS)
Pentavac
A diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus product containing poliovirus inactivated type 2,pertussis toxoid,tetanus toxoid,poliovirus inactivated type 1,poliovirus inactivated type 3,filamentous haemagglutinin,diphtheria toxoid,haemophilus influenzae type b (hib),donor bovine serum, registered in Iceland by Sanofi Winthrop Industrie. The same ATC class is registered in 8 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus is registered in 8 of 19 countries.
Countries holding a registration under ATC J07CA06 (diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus · ATC J07CA06
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Poliovirus inactivated type 2,Pertussis toxoid,Tetanus toxoid,Poliovirus inactivated type 1,Poliovirus inactivated type 3,Filamentous haemagglutinin,Diphtheria Toxoid,HAEMOPHILUS INFLUENZAE TYPE B (HIB),Donor Bovine Serum
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Iceland (IS)
- ATC code
- J07CA06
- ATC class
- Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean4854650,5 ml x10 hglISK 65363
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07CA06
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus, as other registers publish it.
- PolandInfanrix - IPV + HibGlaxoSmithKline Biologicals S.A.
- SwitzerlandInfanrix DTPa-IPV+Hib
- SwitzerlandInfanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer InjektionssuspensionGlaxoSmithKline AG
- BelgiumInfanrix IPV + HibGlaxoSmithKline Biologicals
- SpainINFANRIX-IPV+HIB POLVO Y SUSPENSION PARA SUSPENSION INYECTABLEGlaxosmithkline S.A.
- DenmarkInfanrix-Polio+HibGlaxoSmithKline Pharma A/S
- FinlandInfanrix-Polio+HibGlaxoSmithKline Biologicals SA
- FinlandPediacelSanofi Pasteur Europe
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a923bc06-3c63-4718-a7f6-7ac9d0e7f4f1 GET /v1/drugs/a923bc06-3c63-4718-a7f6-7ac9d0e7f4f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyfsstofn og dreifa, dreifa",
"source": "lyfjastofnun",
"atc_raw": "J07CA06",
"marketed": true,
"strength": null,
"ma_number": "MTnr 970044 (IS)",
"substance": "Poliovirus inactivated type 2,Pertussis toxoid,Tetanus toxoid,Poliovirus inactivated type 1,Poliovirus inactivated type 3,Filamentous haemagglutinin,Diphtheria Toxoid,HAEMOPHILUS INFLUENZAE TYPE B (HIB),Donor Bovine Serum",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "36013"
}See everything about diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.